PharmaLab 2026: AQCG Organises Pre-Conference and APLM Track
Recommendation

Thursday, 3 September 2026 9 .00 - 17.00 h
Establishment, Use and Maintenance of Analytical Reference Substances
PharmaLab 2026 will take place from 23 to 25 November 2026. This year, the event will move to a new venue: the darmstadtium – the Congress Center of Science City Darmstadt, located close to Frankfurt International Airport.
Benefit from 9 parallel conferences and 3 pre-conference workshops, featuring a total of over 130 presentations, around 60 exhibitors, and a networking event, to get your update on the following topics:
Pre-Conferences on 23 November:
- 7th International Mycoplasma qPCR Testing User Day
- Quality Control of mRNA/LNP Products
- Data Quality Management of Aberrant Results - Handling Out of Specification, OOS, and Out of Trend, OOT Results
PharmaLab on 24/25 November:
- Analytical Procedure Lifecycle Management (APLM)
- GMP Compliance Trends Analytical Laboratories
- Bioanalytical Control of Drug Substances and Drug Products
- Cell and Gene Therapies / ATMPs - Quality and Safety
- Bioassays/Potency Assays - Regulatory Requirements, Developments and Routine Use
- Endotoxin and Pyrogen Testing
- Alternative and Rapid Microbiological Methods
- Laboratory Optimization, Automation and Digitalization/Outsourcing in Pharmaceutical Laboratories
- Artificial Intelligence in Laboratories
This year, the ECA Analytical Quality Control Group (AQCG) will organise one of the pre-conference workshops and a dedicated one-day conference track on Analytical Procedure Lifecycle Management (APLM).
Data Quality Management of Aberrant Results
This pre-conference workshop on 23 November aims to strengthen participants’ capability to manage data quality and investigate aberrant results in pharmaceutical laboratories by:
- providing a structured approach to handling Out of Specification (OOS) and Out of Trend (OOT) results,
- explaining key regulatory and guidance expectations and how they translate into practical lab procedures,
- applying trend analysis tools and statistical rules to evaluate OOT signals – incl. understanding common pitfalls and misinterpretations – through an interactive Excel-based exercise.
Analytical Procedure Lifecycle Management (APLM)
This one-day track on 24 November aims to provide a lifecycle-based, risk-driven framework for developing, validating, and maintaining analytical procedures from early development through registration and post-approval change. Participants will learn how to apply current USP updates and use practical case studies (ATP, risk assessment, MODR, validation strategies, precision/replication, platform methods, and OPPV) to define fit-for-purpose validation scope, ensure method robustness and independence, and manage changes in an inspection- and dossier-ready way.
More details can be found on the PharmaLab website. The detailed program and agenda will be published in a few weeks.
Related GMP News
01.07.2026Several FDA Warning Letters and Untitled Letters on Asbestos Testing of Talc in OTC Drug Products
24.06.2026Analytical Quality Group Developments January through April 2026
17.06.2026BioPhorum Publishes a Roadmap for QC Sample Test Execution
03.06.2026EMA Provides an Outlook on the Product-Specific Bioequivalence Guidelines Expected in 2026
03.06.2026FDA Warning Letter: Missing Method Validation - From a QC Topic to a Market-Access Problem
28.05.2026WHO Working Document on Bioequivalence open for Public Consultation


